JEFFREY YORDON - 03 Aug 2021 Form 4 Insider Report for Athenex, Inc. (ATNX)

Role
COO, and President, Athenex Pharmaceutical Division.
Signature
/s/ Teresa Bair, Attorney-in-Fact
Issuer symbol
ATNX
Transactions as of
03 Aug 2021
Transactions value $
$0
Form type
4
Filing time
05 Aug 2021, 16:49:25 UTC
Next filing
21 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATNX Common Stock 237K 03 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNX Stock Option (Right to Buy) Award $0 +50K $0.00 50K 03 Aug 2021 Common Stock 50K $3.80 Direct F3
transaction ATNX Restricted Stock Units Award $0 +50K $0.00 50K 03 Aug 2021 Common Stock 50K Direct F4, F5
holding ATNX Stock Option (Right to Buy) 150K 03 Aug 2021 Common Stock 150K $9.00 Direct
holding ATNX Stock Option (Right to Buy) 212K 03 Aug 2021 Common Stock 212K $11.00 Direct
holding ATNX Stock Option (Right to Buy) 100K 03 Aug 2021 Common Stock 100K $17.30 Direct F1
holding ATNX Stock Option (Right to Buy) 100K 03 Aug 2021 Common Stock 100K $13.17 Direct F2
holding ATNX Stock Option (Right to Buy) 100K 03 Aug 2021 Common Stock 100K $12.45 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in four equal annual installments beginning on March 27, 2019.
F2 This option vests in four equal annual installments beginning on February 28, 2020.
F3 This option vests in four equal annual installments beginning on August 3, 2022.
F4 Each restricted stock unit represents a contingent right to receive one share of stock.
F5 The restricted stock units vest in four equal annual installments beginning on August 3, 2022.

Remarks:

COO, and President, Athenex Pharmaceutical Division.